explore -WSS

explore

author：focus 2025-10-01 21:36:38 - browse：391

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

WSS

Why the world’s most expensive drug might be worth the price

States should stop sabotaging methadone treatment reform

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Scientists boost immune system in aging mice by making it youthful

Merck drug for rare lung condition set for approval in U.S.

Obesity drugs seen as possible treatment for liver disease MASH

hotspot

explore

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

George Santos makes 1st court appearance after pleading not guilty to 13 counts

There's no autism epidemic. It's an autism diagnosis epidemic

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Alabama hospital puts IVF treatments on hold

State Dept. review finds Biden bears some blame for Afghanistan failures

Study says nonprofit hospitals fall short in charity care spending

In age of alternative facts, a scholarly course on calling out crap

Ed Silverman on new gene therapies, biosimilars, coffee, and more

explore

He's a Nobel laureate. Critics say he was misleading on Covid

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Study says nonprofit hospitals fall short in charity care spending

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Alabama frozen embryo ruling has major implications for IVF clinics

knowledge

entertainment

focus

entertainment